Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
Ileana Piña MD, MPH, FAHA, FACC
Ileana L. Piña MD, MPH, FAHA, FACC Advisory Board
Peter Libby MD
Peter Libby MD Advisory Board
See All Experts
featured
Published in Cardiology

Journal Scan / Research · July 30, 2024

Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm

JACC: Clinical Electrophysiology

 

 Save  Recommend
 Share

Additional Info

JACC: Clinical Electrophysiology
Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial
JACC Clin Electrophysiol 2024 Jun 01;10(6)1021-1033, JN Ruskin, AJ Camm, C Dufton, AC Woite-Silva, Y Tuininga, E Badings, JSSG De Jong, T Oosterhof, I Aksoy, AFM Kuijper, IC Van Gelder, V van Dijk, D Nuyens, D Schellings, MY Lee, PR Kowey, HJGM Crijns, J Maupas, L Belardinelli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated